Pharma companies turn to AI to speed up drug development, but hit hurdles
When Genentech licensed experimental drug vixarelimab from Kiniksa Pharmaceuticals, its scientists thought they had a future lung medicine in their hands. Artificial intelligence came up with another plan. It was…
Nifty Pharma drops over 2%, 19 index stocks tumble up to 7%. What triggered this fall?
Stock Market Today: Indian pharma stocks faced significant selling pressure in today’s session, February 10, driven by weak earnings in select companies and fears that former U.S. President Donald Trump…
Glenmark secures MHRA approval to launch Winlevi in the UK
Glenmark Pharmaceuticals (Glenmark) has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to market Winlevi in the United Kingdom. The topical treatment for acne vulgaris is approved…
Drug association ties up with NIPER to set up pharma research centre in Baddi
Facing challenges to access essential technical services, quality testing, research and development, besides regulatory services at competitive rates, a Contract Research Organisation (CRO)-cum-Centre of Excellence is being set up at…
India’s Pharma Industry: Poised for Global Expansion by 2030
India’s pharmaceutical industry is on the verge of major expansion, with its share in the global market predicted to climb to 5% by 2030, according to a new report from…
DGFT Amends Standard Input Output Norms For Erythromycin Stearate Tablets
Mumbai: The Directorate General of Foreign Trade (DGFT), under the ministry of commerce & industry, has announced amendments to the Standard Input Output Norms (SION) for the export of erythromycin…
CSIR-NIIST Develops Technology To Convert Biomedical Waste Into Soil Additives
THIRUVANANTHAPURAM: CSIR-National Institute for Interdisciplinary Science and Technology (NIIST) in Thiruvananthapuram has developed a technology that converts pathogenic biomedical waste into value-added soil additives that eliminate the need for costly…
Pharma stock jumps after it launches Kojiglo serum in India for facial hyperpigmentation
A leading pharmaceutical powerhouse renowned for innovative skincare solutions has unveiled its latest breakthrough in tackling facial hyperpigmentation. The groundbreaking serum, featuring a first-of-its-kind dual liposomal technology in India, promises…
Uniform Code Of Pharmaceuticals Marketing Practices 2024 Outlines Guidelines Regarding Promotion Of Drugs Among Doctors: Minister
New Delhi: With the aim of preventing unethical marketing and ensuring responsible promotion of pharmaceutical products by regulating interactions between doctors / registered medical practitioners (RMPs) and representatives of pharmaceutical…
Dabur reduces strategic review cycle to 3 years amidst short-term volatility, FMCG slowdown
New Delhi: Home-grown FMCG major Dabur has lowered the time of its strategic vision cycle from four years to three years aiming to create a more agile organisation amid a…
